|
|
Volumn 88, Issue 9, 1996, Pages 567-568
|
|
Primary chemotherapy of advanced head and neck cancer: where do we go from here?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIMETABOLITE;
FLUOROURACIL;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
DISEASE COURSE;
EPIDEMIOLOGY;
HEAD AND NECK TUMOR;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
NOTE;
SURVIVAL;
TREATMENT OUTCOME;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, ADJUVANT;
CONFOUNDING FACTORS (EPIDEMIOLOGY);
DISEASE PROGRESSION;
FLUOROURACIL;
HEAD AND NECK NEOPLASMS;
HUMANS;
INJECTIONS, INTRAVENOUS;
RADIOTHERAPY, ADJUVANT;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 0030138277
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/88.9.567 Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|
